ClinicalApplicationsof Bone Marrow aspirate concentrate (BMAC)
Early to moderate osteoarthritis of the knee, hip, shoulder, and ankle → Reduction of synovial inflammation, modulation of the joint microenvironment, pain relief, and functional improvement in athletes with high biomechanical demands.
Meniscal and cartilage lesions → Stimulation of chondrocyte proliferation and repair of fibrocartilaginous and hyaline tissue in sports patients subjected to recurrent joint stress or overload trauma.
Chronic tendinopathies (e.g., Achilles, patellar, rotator cuff) → Regeneration of degenerated tendon tissue, reduction of chronic inflammation, and improvement of local biomechanics in high-impact sports contexts.
Muscle injuries and volumetric muscle loss (VML) → Stimulation of neoangiogenesis, reduction of fibrosis, and recovery of continuity and volume of damaged muscle tissue in athletes with acute or recurrent injuries.
Carpal tunnel syndrome and entrapment neuropathies → Neuroprotective and anti-inflammatory effects on nerve structures, with reduction of neuropathic pain and improved nerve conduction in athletes with overload-related compressions.
Wrist and small joint osteoarthritis → Improved joint mobility, pain symptom reduction, and slowing of joint degeneration in sports disciplines with high distal segment demand (e.g., upper limb use in throwing, gripping, or impact activities).
Roleof mesenchymal stem cells (MSCs)
Cartilage: → Early osteoarthritis of the knee, hip, ankle, and shoulder; tissue regeneration and inflammation reduction. Tendons/Ligaments: → Chronic tendinopathies and partial ligament injuries; promotion of healing and functional recovery. Muscle: → Traumatic or overload injuries; stimulation of repair and vascularization. Small joints and fascia: → Plantar fasciitis and minor joint degeneration; anti-inflammatory
Clinicaleffectsof Bone Marrow Aspirate Concentrate (BMAC)
Anti-inflammatory Effect: → Mesenchymal stromal cells (MSCs) in BMAC modulate the inflammatory response through secretion of anti-inflammatory cytokines (IL-10, TGF-β). They reduce pain and edema in injured tissues, improving joint load tolerance. They promote macrophage polarization from pro-inflammatory (M1) to regenerative (M2) phenotype. Regenerative Effect: → Stimulate the proliferation and differentiation of resident cells (chondrocytes, tenocytes, myocytes). Promote neoangiogenesis and tissue remodeling. Support extracellular matrix synthesis, enhancing tissue repair quality. Analgesic Effect: → The anti-inflammatory and regenerative actions lead to significant pain reduction, even in chronic conditions. May reduce the need for NSAIDs or corticosteroid injections. Immunomodulatory Effect: → MSCs interact with immune cells (lymphocytes, macrophages, dendritic cells), dampening autoimmune responses. Useful in degenerative and inflammatory joint diseases of microtraumatic origin. Functional Improvement: → Increased joint range of motion, enhanced muscle strength, and improved performance in functional tests. Faster recovery times after injuries or surgeries.
ClinicalApplicationsof BMAC in Sports Medicine
In the sports field, BMAC is indicated both as a conservative treatment and as intraoperative biological support in the following conditions:
• Chronic tendinopathies (Achilles, patellar, lateral epicondyle) • Recurrent muscle injuries • Focal or diffuse joint chondropathies • Partial or unstable lesions of the meniscus and cruciate ligament • Arthroscopic repairs of the rotator cuff
The goal is to modulate the inflammatory response, promote tissue regeneration, and shorten functional recovery times in athletes and active individuals.